2m 2m 2m 2m 2m 2m 2m
Amgen (AMGN)
NASDAQ
$377.83+$0.47 (+0.13%)
Price as of Sep 11, 2026 7:59 PM EDT- $206.8BMarket Cap
- 40.32%1-Year Change
- Drug Manufacturers - GeneralIndustry
Amgen (AMGN)
$377.83+$0.47 (+0.13%)
AMGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $377.35 | ||
Change | -$5.12 (-1.34%) | ||
Open | $386.13 | ||
High | $386.99 | ||
Low | $377.22 | ||
Previous Close | $382.47 | ||
Volume | 2,291,617 | ||
30-Day Average Volume | 2,557,105 | ||
1-Week Change | -13.70% | ||
1-Month Change | -8.39% | ||
1-Year Change | 40.32% | ||
3-Year Change | 57.74% | ||
5-Year Change | 106.26% | ||
Fundamentals | |||
Shares Outstanding | 540.6M | ||
Total Assets | $95.6B | ||
Market Cap | $206.8B | ||
Enterprise Value | $250.1B | ||
Period: QTR TTM FY | |||
Revenue | $9.5B | ||
Net Income | $2.4B | ||
Free Cash Flow | $3.5B | ||
EBIT | $3.4B | ||
EBITDA | $4.6B | ||
Net Working Capital | $9.5B | ||
EPS | $4.37 | ||
Enterprise Value/EBITDA | 55 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 17 | ||
P/E | 86 | ||
PEG | 3 | ||
Price/Free Cash Flow | 58 | ||
Price/Operating Cash Flow | 51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.67% | ||
Trailing Annual Dividend Yield | 2.63% | ||
Ex-Dividend Date | 08/21/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield